John Kenneth Amory serves as Executive at Clarus Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, John Kenneth Amory has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 7, 2022 involved receiving (via award) 1,922 shares valued at $0.
John Kenneth Amory currently holds 5,766 shares of Clarus Therapeutics Holdings, Inc. (CRXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Kenneth Amory has been a net neutral trader of CRXT stock. They have purchased $0 and sold $0 worth of shares.
John Kenneth Amory's most recent insider trade was on Jun 7, 2022, when they sold 1,922 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |